The role of migraine as an independent risk factor for cardiovascular events has been debated for several years, while it is more established for ischemic stroke. Recently, new studies have examined the likelihood of migraine to determine cardiovascular events, supporting the hypothesis of a predominant role in patients with migraine with aura, the risk including both sexes. In the literature, multiple pathophysiological mechanisms are described to explain this association, and are here discussed. Furthermore, the emerging evidence that a higher headache frequency and long-term migraine may worsen the cardio-metabolic profile in migraineurs (e.g. with a higher Framingham risk score and risk of developing atherosclerosis, insulin resistance and metabolic syndrome) makes it increasingly necessary to reduce the number and severity of attacks, not only to alleviate the painful symptoms, but also to improve the prognosis in these patients.

New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?

TANA, CLAUDIO;TAFURI, EMMANUELE;TANA, MARCO;AFFAITATI, GIANNA PIA;FABRIZIO, ALESSANDRA;COSTANTINI, Raffaele;MEZZETTI, Andrea;GIAMBERARDINO, Maria Adele
2013-01-01

Abstract

The role of migraine as an independent risk factor for cardiovascular events has been debated for several years, while it is more established for ischemic stroke. Recently, new studies have examined the likelihood of migraine to determine cardiovascular events, supporting the hypothesis of a predominant role in patients with migraine with aura, the risk including both sexes. In the literature, multiple pathophysiological mechanisms are described to explain this association, and are here discussed. Furthermore, the emerging evidence that a higher headache frequency and long-term migraine may worsen the cardio-metabolic profile in migraineurs (e.g. with a higher Framingham risk score and risk of developing atherosclerosis, insulin resistance and metabolic syndrome) makes it increasingly necessary to reduce the number and severity of attacks, not only to alleviate the painful symptoms, but also to improve the prognosis in these patients.
File in questo prodotto:
File Dimensione Formato  
New insights.pdf

accesso aperto

Tipologia: PDF editoriale
Dimensione 493.72 kB
Formato Adobe PDF
493.72 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/441291
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 46
social impact